Fight for the things that matter

What are you fighting for?
TYSABRI can help in 3 important ways

In a 2-year study of 627 people treated with TYSABRI versus 315 people taking placebo, TYSABRI was significantly more effective in slowing the progression of physical disability over a period of 12 weeks, reducing the formation of new active brain lesions, and reducing the number of relapses. Want to learn more about TYSABRI? Sign up for TYSABRI emails here

TYSABRI has been proven effective in delaying the progression of physical disability

of people treated with TYSABRI had no progression of physical disability over a period of 12 weeks*

  • 17% of people treated with TYSABRI had worsening physical disability, compared with 29% of people taking placebo

TYSABRI has been proven effective in reducing new lesion activity within the brain

of people treated with TYSABRI had no new lesions that showed disease activity on an MRI*

  • Compared with 72% of people taking placebo

TYSABRI has been proven to reduce relapses

of people taking TYSABRI remained relapse free*

  • 67% of people taking TYSABRI were relapse free, compared with 41% of people taking placebo

*In a 2-year study of 627 people treated with TYSABRI versus 315 taking placebo.

FIGHTER FACT
  • MRI scans are important because they are useful in tracking the progress of your disease. What’s more, your doctor may use the results of your scan, along with other information, to determine whether your current treatment is effective or if a change should be considered.
  • Reducing the frequency of your relapses is important because disabilities that develop during a relapse could be lasting. In fact, approximately 50% of people suffer lasting effects after a disabling relapse. Every relapse matters. That’s why it’s important to work with your healthcare team to reduce the number of relapses you experience each year.
Speak
up

Start a conversation about TYSABRI with your doctor

Find your
infusion site

Find the TOUCH-authorized infusion site nearest you

Benefits
vs risks

Find what you need to know about PML and the JC Virus